Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001864916 | SCV002118289 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2022-03-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004039732 | SCV004915146 | uncertain significance | Inborn genetic diseases | 2024-03-04 | criteria provided, single submitter | clinical testing | The c.3563C>T (p.P1188L) alteration is located in exon 17 (coding exon 16) of the CACNA1H gene. This alteration results from a C to T substitution at nucleotide position 3563, causing the proline (P) at amino acid position 1188 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |